These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26920603)

  • 1. Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial.
    Acharjee S; Teo KK; Jacobs AK; Hartigan PM; Barn K; Gosselin G; Tanguay JF; Maron DJ; Kostuk WJ; Chaitman BR; Mancini GB; Spertus JA; Dada MR; Bates ER; Booth DC; Weintraub WS; O'Rourke RA; Boden WE;
    Am Heart J; 2016 Mar; 173():108-17. PubMed ID: 26920603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial).
    Padala SK; Sidhu MS; Hartigan PM; Maron DJ; Teo KK; Spertus JA; Mancini GB; Sedlis SP; Chaitman BR; Heller GV; Weintraub WS; Boden WE
    Am J Cardiol; 2015 Nov; 116(10):1509-15. PubMed ID: 26410604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
    Shaw LJ; Berman DS; Maron DJ; Mancini GB; Hayes SW; Hartigan PM; Weintraub WS; O'Rourke RA; Dada M; Spertus JA; Chaitman BR; Friedman J; Slomka P; Heller GV; Germano G; Gosselin G; Berger P; Kostuk WJ; Schwartz RG; Knudtson M; Veledar E; Bates ER; McCallister B; Teo KK; Boden WE;
    Circulation; 2008 Mar; 117(10):1283-91. PubMed ID: 18268144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).
    Boden WE; O'Rourke RA; Teo KK; Maron DJ; Hartigan PM; Sedlis SP; Dada M; Labedi M; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    Am J Cardiol; 2009 Jul; 104(1):1-4. PubMed ID: 19576311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
    Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
    Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of a randomized, controlled clinical trial of three therapeutic strategies for multivessel stable coronary artery disease in women.
    Mansur Ade P; Hueb WA; Takada JY; Avakian SD; Soares PR; Garzilo CL; Kalil Filho R; Ramires JA
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):997-1001. PubMed ID: 25183741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of female sex on long-term outcomes in patients with ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Ferrante G; Corrada E; Belli G; Zavalloni D; Scatturin M; Mennuni M; Gasparini GL; Bernardinelli L; Cianci D; Pastorino R; Rossi ML; Pagnotta P; Presbitero P
    Can J Cardiol; 2011; 27(6):749-55. PubMed ID: 21924580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study.
    Guagliumi G; Capodanno D; Saia F; Musumeci G; Tarantini G; Garbo R; Tumminello G; Sirbu V; Coccato M; Fineschi M; Trani C; De Benedictis M; Limbruno U; De Luca L; Niccoli G; Bezerra H; Ladich E; Costa M; Biondi Zoccai G; Virmani R;
    JACC Cardiovasc Interv; 2014 Sep; 7(9):958-68. PubMed ID: 25129664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex difference in clinical outcomes after percutaneous coronary intervention in Korean population.
    Park DW; Kim YH; Yun SC; Ahn JM; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    Am Heart J; 2014 May; 167(5):743-52. PubMed ID: 24766986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience.
    Aksoy O; Tuzcu EM; Ellis SG; Whitlow PL; Cam A; Batizy L; Agarwal S; Franco I; Bajzer C; Simpfendorfer C; Raymond R; Nair R; Cho L; Shishehbor MH; Lincoff AM; Kapadia SR
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E1-8. PubMed ID: 22508442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the appropriate use criteria for percutaneous coronary intervention in patients with stable coronary artery disease (from the COURAGE trial).
    Bradley SM; Chan PS; Hartigan PM; Nallamothu BK; Weintraub WS; Sedlis SP; Dada M; Maron DJ; Kostuk WJ; Berman DS; Teo KK; Mancini GB; Boden WE; Spertus JA
    Am J Cardiol; 2015 Jul; 116(2):167-73. PubMed ID: 25960375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
    Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
    JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radial Versus Femoral Access for Coronary Angiography/Intervention in Women With Acute Coronary Syndromes: Insights From the RIVAL Trial (Radial Vs femorAL access for coronary intervention).
    Pandie S; Mehta SR; Cantor WJ; Cheema AN; Gao P; Madan M; Niemela K; Rao SV; Schwalm JD; Valentin V; Velianou JL; Jolly SS
    JACC Cardiovasc Interv; 2015 Apr; 8(4):505-12. PubMed ID: 25907080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.